Literature DB >> 8742438

GDNF reduces apoptosis in dopaminergic neurons in vitro.

E D Clarkson1, W M Zawada, C R Freed.   

Abstract

To explore the mechanism by which glial cell line-derived neurotrophic factor (GDNF) improves cell survival, we measured the apoptotic rate of dopamine neurons incubated with GDNF. Cultures were prepared from embryonic day 15 rat mesencephalon in medium with 5% human placental serum. GDNF reduced the rate of apoptosis in dopamine neurons from 5% to 2%. By contrast, GDNF had no effect on apoptoisis in astrocytes from embryonic mesencephalon or from neonatal cortex. Co-cultures with embryonic striatum as well as with combinations of growth factors were also tested for effects on dopamine neuron survival. Neuronal survival was maximal during co-culture with striatal cells with or without added growth factors. We conclude that GDNF inhibits apoptotic cell death in dopamine neurons.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8742438

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  16 in total

1.  Intranasal Administration of GDNF Protects Against Neural Apoptosis in a Rat Model of Parkinson's Disease Through PI3K/Akt/GSK3β Pathway.

Authors:  Peijian Yue; Lin Gao; Xuejing Wang; Xuebing Ding; Junfang Teng
Journal:  Neurochem Res       Date:  2017-02-28       Impact factor: 3.996

Review 2.  Roles for the TGFβ superfamily in the development and survival of midbrain dopaminergic neurons.

Authors:  Shane V Hegarty; Aideen M Sullivan; Gerard W O'Keeffe
Journal:  Mol Neurobiol       Date:  2014-02-07       Impact factor: 5.590

3.  Gene expression in skin, muscle, and dorsal root ganglion after plantar incision in the rat.

Authors:  Christina M Spofford; Timothy J Brennan
Journal:  Anesthesiology       Date:  2012-07       Impact factor: 7.892

4.  Effects of glial cell line-derived neurotrophic factor deletion on ventral mesencephalic organotypic tissue cultures.

Authors:  Sara af Bjerkén; Heather A Boger; Matthew Nelson; Barry J Hoffer; Ann-Charlotte Granholm; Ingrid Strömberg
Journal:  Brain Res       Date:  2006-12-19       Impact factor: 3.252

5.  GDNF: a novel factor with therapeutic potential for neurodegenerative disorders.

Authors:  K M Walton
Journal:  Mol Neurobiol       Date:  1999-02       Impact factor: 5.590

6.  Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats.

Authors:  R J Mandel; S K Spratt; R O Snyder; S E Leff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

7.  Purified mouse dopamine neurons thrive and function after transplantation into brain but require novel glial factors for survival in culture.

Authors:  A E Donaldson; C E Marshall; Ming Yang; S Suon; Lorraine Iacovitti
Journal:  Mol Cell Neurosci       Date:  2005-09       Impact factor: 4.314

8.  IGF-1 and bFGF reduce glutaric acid and 3-hydroxyglutaric acid toxicity in striatal cultures.

Authors:  K B Bjugstad; W M Zawada; S Goodman; C R Freed
Journal:  J Inherit Metab Dis       Date:  2001-11       Impact factor: 4.982

9.  The effect of interferon-beta on mouse neural progenitor cell survival and differentiation.

Authors:  Marek Hirsch; Julia Knight; Mari Tobita; John Soltys; Hillel Panitch; Yang Mao-Draayer
Journal:  Biochem Biophys Res Commun       Date:  2009-07-18       Impact factor: 3.575

Review 10.  Therapeutic potential of nerve growth factors in Parkinson's disease.

Authors:  T J Collier; C E Sortwell
Journal:  Drugs Aging       Date:  1999-04       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.